↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ

ABCDEFGH I JKLMNOPQRSTUVWXYZother

216 / 17,542 descriptions

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 指定難病告示番号
1 1-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride Piperazine 6件: D00807, D01393, D02127, D02145, D05486, D06224 💬 - - 1件: 58 💬
2 10% metronidazole ointment Metronidazole 3件: D00409, D05016, D05017 💬 - - 1件: 96 💬
3 Administration of rituximab and methylprednisolone Methylprednisolone 7件: D00407, D00751, D00979, D02994, D05000, D05001, D05002 💬 2件: MS4A1, NR3C1 💬 2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 1件: 51 💬
4 Aluminium phosphate Aluminium - - - 1件: 46 💬
5 Amifampridine phosphate Amifampridine 1件: D10228 💬 4件: KCNA4, KCNC3, KCND2, KCND3 💬 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 3件:  3 , 11, 12 💬
6 Amifampridine phosphate 10 mg oral tablet Amifampridine 1件: D10228 💬 4件: KCNA4, KCNC3, KCND2, KCND3 💬 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 1件:  3  💬
7 Amoxicillin, metronidazole and tetracycline Amoxicillin 7件: D00201, D00229, D00409, D02925, D05016, D05017, D07452 💬 - - 1件: 97 💬
8 Azd4017 and prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 75 💬
9 Azithromycin + metronidazole Azithromycin 6件: D00409, D02134, D05016, D05017, D06390, D07486 💬 - - 1件: 96 💬
10 Betamethasone Betamethasone 7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 6件:  2 , 28, 46, 90, 96, 235 💬
11 Betamethasone acibutate Betamethasone 7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
12 Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days Acetate 7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件:  2  💬
13 Bladder instillation with triamcinolone acetonide Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 226 💬
14 Bladder instillation without triamcinolone acetonide Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 226 💬
15 Bortezomib/dexamethasone Bortezomib 10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150 💬 2件: NR3C1, PSMB5 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 283 💬
16 Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone Bortezomib 10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150 💬 2件: NR3C1, PSMB5 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 28 💬
17 Bupivacaine/epinephrine/dexamethasone Bupivacaine 14件: D00095, D00292, D00975, D00996, D01450, D01510, D01615, D01632, D01948, D02149, D02174, D02591, D02592, D07552 💬 15件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 96 💬
18 Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen) Antithymocyte immunoglobulin (rabbit) 5件: D00248, D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 326 💬
19 Busulfan, fludarabine and atg Busulfan 3件: D00248, D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 65 💬
20 Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine. Busulfan 6件: D00184, D00248, D00287, D01907, D07760, D07966 💬 6件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬 37件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 2件: 60, 285 💬
21 Busulfan, fludarabine, atg, tli Busulfan 3件: D00248, D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 2件: 65, 284 💬
22 Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf Busulfan 8件: D00107, D00142, D00248, D01907, D02115, D03235, D07966, D08556 💬 9件: CSF3R, DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬 46件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Drug metabolism - other enzymes, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 1件: 60 💬
23 Campath, fludarabine, cyclophosphamide Cyclophosphamide 4件: D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 2件: 65, 284 💬
24 Carmustine, etoposide, cytarabine, and melphalan (beam) Carmustine 7件: D00125, D00168, D00254, D00369, D03046, D03637, D04107 💬 2件: TOP2A, TOP2B 💬 1件: Platinum drug resistance 1件: 13 💬
25 Carvedilol Carvedilol 2件: D00255, D03415 💬 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 5件:  6 , 57, 86, 113, 210 💬
26 Chloroquine Chloroquine 3件: D02125, D02366, D03469 💬 - - 3件: 46, 49, 95 💬
27 Chloroquine diphosphate Chloroquine 3件: D02125, D02366, D03469 💬 - - 1件: 95 💬
28 Chloroquine diphosphate 250mg Chloroquine 3件: D02125, D02366, D03469 💬 - - 1件: 95 💬
29 Clindamycin Clindamycin 4件: D00277, D01073, D01990, D02132 💬 - - 2件: 46, 299 💬
30 Cofactor supplementation (thiamine, riboflavin, l-carnitine) Levocarnitine 7件: D00050, D01622, D01913, D02030, D02176, D04713, D08580 💬 - - 1件: 265 💬
31 Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine Azathioprine 12件: D00238, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D02994, D03033 💬 2件: MS4A1, NR3C1 💬 2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 1件: 35 💬
32 Combination therapy with vigabatrin and prednisolone Prednisolone 9件: D00472, D00535, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 2件: ABAT, NR3C1 💬 8件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 1件: 145 💬
33 Control intervention (no dexamethasone) Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
34 Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) Acetate 21件: D00088, D00292, D00472, D00473, D00973, D00975, D00980, D00981, D00982, D01239, D01510, D01615, D01632, D01948, D01998, D02156, D02174, D02591, D02592, D03301, D07749 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
35 Corticosteroid (prednisolone) Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 85 💬
36 Corticosteroid treatment (methylprednisolone or prednisolone) Methylprednisolone 14件: D00407, D00472, D00751, D00979, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 64 💬
37 Corticosteroids (prednisone or prednisolone) Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 49 💬
38 Cyclophosphamide and fludarabine Cyclophosphamide 4件: D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 13 💬
39 Cyclophosphamide, azathioprine,prednisone,methylprednisolone Azathioprine 11件: D00238, D00287, D00407, D00473, D00751, D00979, D03033, D05000, D05001, D05002, D07760 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 42, 43, 45 💬
40 Cyclophosphamide, bortezomib, and dexamethasone (cybord) Bortezomib 12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬 2件: NR3C1, PSMB5 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 28 💬
41 Cyclophosphamide, bortezomib, dexamethasone Bortezomib 12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬 2件: NR3C1, PSMB5 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 28 💬
42 Cyclophosphamide, bortezomib, dexamethasone plus daratumumab Bortezomib 13件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760, D10777 💬 3件: CD38, NR3C1, PSMB5 💬 16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 1件: 28 💬
43 Cyclophosphamide, fludarabine Cyclophosphamide 4件: D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 285 💬
44 Cyclophosphamide, fludarabine , thymoglobulin Antithymocyte immunoglobulin (rabbit) 4件: D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 60 💬
45 Cyclophosphamide, fludarabine, rabbit atg Antithymocyte immunoglobulin (rabbit) 4件: D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 60 💬
46 Cyclophosphamide, fludarabine, thymoglobulin Antithymocyte immunoglobulin (rabbit) 4件: D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 60 💬
47 Dalacin c phosphate Phosphate ion - - - 1件: 46 💬
48 Decadron phosphate, injectable Phosphate ion - - - 1件: 70 💬
49 Device: dexamethasone injection Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 90 💬
50 Dexamethasone Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
51 Dexamethasone (1 cycle) Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 63 💬
52 Dexamethasone (4 cycles) Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 63 💬
53 Dexamethasone (50mg 1dd6, 3 consecutive days/month) Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 35 💬
54 Dexamethasone 0,1 mg tablets Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
55 Dexamethasone 0,5mg Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 84 💬
56 Dexamethasone 0.5mg tablet Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
57 Dexamethasone 0.5mg/5ml solution Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 35, 162 💬
58 Dexamethasone 0.5mg/5ml solution in mucolox™ Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 35, 162 💬
59 Dexamethasone 1,5 mg tablets Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
60 Dexamethasone 21-dihydrogen phosphate Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 65 💬
61 Dexamethasone 21-phosphate Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
62 Dexamethasone 2mg tablets Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
63 Dexamethasone 4 mg jenapharm Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 28 💬
64 Dexamethasone abcur Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 63 💬
65 Dexamethasone and rituximab Dexamethasone 10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D02994 💬 2件: MS4A1, NR3C1 💬 2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 1件: 63 💬
66 Dexamethasone oral tablet 8mg (dexamethasone krka tablets(8mg), warsaw, poland). Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 235 💬
67 Dexamethasone parotid irrigation Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 53 💬
68 Dexamethasone sodium phosphate Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 65, 70, 96 💬
69 Dexamethasone sodium phosphate 250 mg/ 10 ml Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 96 💬
70 Dexamethasone sodium phosphate 250 mg/10 ml solution Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 299 💬
71 Dexamethasone sodium phosphate ph. eur. Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 65 💬
72 Dexamethasone sodium sulfate Dexamethasone 11件: D00292, D00975, D01510, D01615, D01632, D01732, D01948, D02174, D02591, D02592, D05877 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 28 💬
73 Dexamethasone soduim phosphate Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 13 💬
74 Dexamethasone, 40 mg Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 28 💬
75 Diagnostic test: dexamethasone test Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 75 💬
76 Etanercept, methotrexate, prednisolone Etanercept 11件: D00142, D00472, D00742, D00980, D00981, D00982, D01239, D01998, D02115, D02156, D03301 💬 5件: DHFR, DHFR2, LTA, NR3C1, TNF 💬 70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 56 💬
77 Etoposide Etoposide 2件: D00125, D04107 💬 2件: TOP2A, TOP2B 💬 1件: Platinum drug resistance 11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬
78 Fludarabine Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬
79 Fludarabine (flu) Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 2件: 60, 285 💬
80 Fludarabine monophosphate Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 3件: 65, 284, 326 💬
81 Fludarabine phosphate Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 11件: 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285 💬
82 Fludarabine phosphate 30 mg Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 2件: 65, 164 💬
83 Fludarabine phosphate 40 mg Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 2件: 65, 164 💬
84 Fludarabine, busulfan, thymoglobulin Antithymocyte immunoglobulin (rabbit) 3件: D00248, D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 65 💬
85 Fludarabine, cyclophosphamide Cyclophosphamide 4件: D00287, D01907, D07760, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 60 💬
86 Fludarabine, melphalan, thiotepa Fludarabine 4件: D00369, D00583, D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 65 💬
87 Fludarabine/ melphalan Fludarabine 3件: D00369, D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 60 💬
88 Fludarabine/busulfan Busulfan 3件: D00248, D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 60 💬
89 Glucocorticoid (prednisone or prednisolone) Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 84 💬
90 High dose dexamethasone pulses Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 63 💬
91 Hydrocortisone sodium phosphate Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 53, 81, 83 💬
92 Hydroxychloroquine or chloroquine Chloroquine 4件: D02125, D02366, D03469, D08050 💬 - - 1件: 49 💬
93 Incb028050 phosphate Phosphate ion - - - 1件: 46 💬
94 Incb028050 phosphate salt Phosphate ion - - - 1件: 46 💬
95 Infigratinib phosphate Infigratinib 1件: D11589 💬 3件: FGFR1, FGFR2, FGFR3 💬 21件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 1件: 276 💬
96 Infliximab, methylprednisolone, methotrexate Infliximab 9件: D00142, D00407, D00751, D00979, D02115, D02598, D05000, D05001, D05002 💬 4件: DHFR, DHFR2, NR3C1, TNF 💬 70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
97 Interferon-beta-1a (avonex) plus methylprednisolone Human interferon beta 7件: D00407, D00751, D00979, D04554, D05000, D05001, D05002 💬 3件: IFNAR1, IFNAR2, NR3C1 💬 19件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 1件: 13 💬
98 Intra plexus triamcinolone and bupivicaine injection Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 298 💬
99 Intra-articular compound betamethasone Betamethasone 7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
100 Intraarticular betamethasone Betamethasone 7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
101 Intraarticular dexamethasone Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
102 Intravenous (i.v.) methylprednisolone 1000 mg, total 9 Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 222 💬
103 Intravenous dexamethasone 1 mg Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
104 Intravenous methyl prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 43 💬
105 Intravenous methylprednisolone Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 13, 145 💬
106 Iv methylprednisolone Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 13 💬
107 Iv methylprednisolone (steroids) Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 13 💬
108 Lenalidomide and dexamethasone Dexamethasone 10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687 💬 2件: NR3C1, TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 16 💬
109 Lenalidomide+dexamethasone Dexamethasone 10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687 💬 2件: NR3C1, TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 16 💬
110 Lenalidomide, dexamethasone Dexamethasone 10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687 💬 2件: NR3C1, TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 16 💬
111 Lenalidomide, dexamethasone and cyclophosphamide Cyclophosphamide 12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687, D07760 💬 2件: NR3C1, TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 28 💬
112 Lodotra (delayed release prednisolone) Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 41 💬
113 Long-circulating liposomal prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
114 Low dose prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 84 💬
115 Medium dose prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 84 💬
116 Megadose oral methylprednisolone Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 13 💬
117 Melphalan, thalidomide and dexamethasone Dexamethasone 11件: D00292, D00369, D00754, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 2件: NR3C1, TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 28 💬
118 Methotrexate + methylprednisolone Methotrexate 8件: D00142, D00407, D00751, D00979, D02115, D05000, D05001, D05002 💬 3件: DHFR, DHFR2, NR3C1 💬 6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 1件: 46 💬
119 Methotrexate - etanercept - prednisolone arm Etanercept 11件: D00142, D00472, D00742, D00980, D00981, D00982, D01239, D01998, D02115, D02156, D03301 💬 5件: DHFR, DHFR2, LTA, NR3C1, TNF 💬 70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
120 Methyl prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 43, 49, 96 💬
121 Methylprednisolone Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 44件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
122 Methylprednisolone (drug) Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 13 💬
123 Methylprednisolone (mp) Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 60, 285 💬
124 Methylprednisolone (mp) or prednisone (pred) Methylprednisolone 7件: D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 66 💬
125 Methylprednisolone (or other glucocorticoid) Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 43 💬
126 Methylprednisolone (solu-medrol) Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 14 💬
127 Methylprednisolone 1250 mg/24h x3 days Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 13 💬
128 Methylprednisolone acetate Acetate 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 51 💬
129 Methylprednisolone bolus iv 15 mg/kg/d for 3 days. Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 84 💬
130 Methylprednisolone hemisuccinate Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 13 💬
131 Methylprednisolone iv Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 13 💬
132 Methylprednisolone mylan générique Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 66 💬
133 Methylprednisolone or budesonide Budesonide 7件: D00246, D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 96 💬
134 Methylprednisolone or prednisolone Methylprednisolone 14件: D00407, D00472, D00751, D00979, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 65 💬
135 Methylprednisolone po Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 13 💬
136 Methylprednisolone pulse Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 66, 220 💬
137 Methylprednisolone sodium hemisuccinate Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 13, 97 💬
138 Methylprednisolone sodium succinate Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 6件: 13, 46, 49, 50, 51, 211 💬
139 Methylprednisolone(intravenously in the 1st-2nd-3rd month ) Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 66 💬
140 Methylprednisolone(intravenously in the 1st-3rd-5th month) Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 66 💬
141 Metronidazole Metronidazole 3件: D00409, D05016, D05017 💬 - - 8件: 46, 51, 63, 94, 95, 96, 97, 291 💬
142 Metronidazole capsule 50 mg Metronidazole 3件: D00409, D05016, D05017 💬 - - 1件: 97 💬
143 Mmf and dexamethasone Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 222 💬
144 Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone Mesalazine 7件: D00377, D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
145 Oral methylprednisolone 625 mg/24h x3 days Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 13 💬
146 Oral prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 49, 145 💬
147 Oseltamivir Oseltamivir 2件: D00900, D08306 💬 - - 2件: 97, 299 💬
148 Other: hydroxychloroquine/chloroquine Chloroquine 4件: D02125, D02366, D03469, D08050 💬 - - 1件: 46 💬
149 Overencapsulated prednisolone tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
150 Paroxetine & prednisolone Paroxetine 12件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬 2件: NR3C1, SLC6A4 💬 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 1件: 46 💬
151 Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp Paroxetine 12件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬 2件: NR3C1, SLC6A4 💬 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 1件: 46 💬
152 Paroxetine hydrochloride tablets 10 & 20 mg and prednisolone 1 mg bp Paroxetine 12件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬 2件: NR3C1, SLC6A4 💬 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 1件: 46 💬
153 Peg-liposomal prednisolone sodium phosphate Phosphate ion 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 13, 97 💬
154 Peri-neural dexamethasone 1 mg Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
155 Phosphate Phosphate ion - - - 30件:  2 ,  3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬
156 Phosphate and betamethasone acetate, 2 ml. Acetate 7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 235 💬
157 Phosphate sandoz Phosphate ion - - - 1件: 78 💬
158 Phosphate-buffered saline Phosphate ion - - - 1件: 49 💬
159 Piperazine Piperazine 6件: D00807, D01393, D02127, D02145, D05486, D06224 💬 - - 1件: 58 💬
160 Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate Aluminium - - - 1件: 46 💬
161 Pomalidomide and dexamethasone Dexamethasone 10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D08976 💬 3件: IL6, NR3C1, TNF 💬 79件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 28 💬
162 Prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
163 Prednisolone & dipyridamole Dipyridamole 9件: D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 3件: NR3C1, PDE4A, PDE5A 💬 7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 46 💬
164 Prednisolone + mabthera Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 61 💬
165 Prednisolone 1mg tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
166 Prednisolone 2,5 mg tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
167 Prednisolone 20 mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
168 Prednisolone 40 mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
169 Prednisolone 5 mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 46, 51 💬
170 Prednisolone 5 mg jenapharm Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 41 💬
171 Prednisolone 5 mg tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
172 Prednisolone 5mg gastro-resistant tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 51 💬
173 Prednisolone 5mg tablet Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
174 Prednisolone acetate Acetate 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 222 💬
175 Prednisolone and chlorambucil Chlorambucil 9件: D00266, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 222 💬
176 Prednisolone and mycophenolate mofetil Mycophenolate mofetil 12件: D00472, D00752, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05094, D05095, D05096 💬 3件: IMPDH1, IMPDH2, NR3C1 💬 4件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 1件: 222 💬
177 Prednisolone and taper Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 51 💬
178 Prednisolone labesfal Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
179 Prednisolone sodium metasulphobenzoate Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
180 Prednisolone sodium phosphate Phosphate ion 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 13, 97 💬
181 Prednisolone sodium succinate Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 95 💬
182 Prednisolone tablets b.p. 5mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
183 Prednisolone tablets bp Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
184 Prednisolone tablets bp 1 mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
185 Prednisolone tablets usp 5 mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
186 Prednisolone-dipyridamole Dipyridamole 9件: D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 3件: NR3C1, PDE4A, PDE5A 💬 7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 46 💬
187 Prednisolone/prednisone Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 49 💬
188 Prednisone (and methylprednisolone) Methylprednisolone 7件: D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 43 💬
189 Prednisone or prednisolone Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 66 💬
190 Prednisone, methylprednisolone,cyclophosphamides Methylprednisolone 7件: D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 42, 43, 45 💬
191 Prednisone/prednisolone Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 35 💬
192 Procedure: celiac block with triamcinolone and bupivicaine Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 298 💬
193 Procedure: epidural steroid (dexamethasone) injection Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 70 💬
194 Pyridoxine plus prednisolone Prednisolone 10件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02179, D03301, D08454 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 145 💬
195 Recombinant human ?-glucosidase conjugated with synthetic bismannose-6-phosphate-man6 glycan Phosphate ion - - - 1件: 256 💬
196 Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan (neogaa) Avalglucosidase alfa 1件: D11744 💬 1件: GAA 💬 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 1件: 256 💬
197 Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan avalglucosidase alfa (neogaa) Avalglucosidase alfa 1件: D11744 💬 1件: GAA 💬 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 1件: 256 💬
198 Riboflavin Riboflavin 3件: D00050, D01622, D01913 💬 - - 8件: 13, 38, 46, 96, 97, 162, 168, 265 💬
199 Riboflavin sodium phosphate injection Phosphate ion 3件: D00050, D01622, D01913 💬 - - 1件: 96 💬
200 Riboflavin supplementation Riboflavin 3件: D00050, D01622, D01913 💬 - - 1件: 96 💬
201 Soluble prednisolone tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 145 💬
202 Spironolactone captopril carvedilol Captopril 4件: D00251, D00255, D00443, D03415 💬 7件: ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬 18件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
203 Sq fludarabine Fludarabine 2件: D01907, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 49 💬
204 Sulphasalazine + hydroxychloroquine or prednisolone Hydroxychloroquine 9件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D08050 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
205 Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication) Amoxicillin 7件: D00229, D00276, D00409, D02925, D05016, D05017, D07452 💬 - - 1件: 63 💬
206 Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan Alemtuzumab 5件: D00369, D00583, D01907, D02802, D07966 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 2件: 65, 164 💬
207 Trexan+salazopyrin+oxiklorin+prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
208 Trexan+salazopyrin+oxiklorin+prednisolone + infliximab Infliximab 9件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02598, D03301 💬 2件: NR3C1, TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
209 Triamcinolone Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 8件: 35, 46, 56, 70, 90, 96, 226, 298 💬
210 Triamcinolone 40 milligrams (kenacort, bristol myers squip) Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
211 Triamcinolone acetonide Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 35, 46, 56 💬
212 Triamcinolone acetonide and normal saline solution Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 70 💬
213 Triamcinolone hexacetonid (lederspan) Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
214 Triamcinolone hexacetonide Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
215 Triamcinolone hexacetonide (lederspan) Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
216 Z102 (prednisolone and dipyridamole). Dipyridamole 9件: D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 3件: NR3C1, PDE4A, PDE5A 💬 7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 46 💬

先頭へ